Re-inventing Drug Development

The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. Th

Industria biofarmaceutica a intrat intr-o era de schimbari si provocari fara precedent, caracterizata prin cresterea presiunilor asupra preturilor, rate in crestere de uzura in ciclul de viata al dezvoltarii produselor si scaderea inovatiei stiintifice. Cele mai de succes produse pierd protectia brevetului, iar conductele nu au reusit sa umple golul.